Skip to content

Advertisement

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU

  • Fleur P. Paling1Email authorView ORCID ID profile,
  • Darren P. R. Troeman1,
  • Martin Wolkewitz2,
  • Rubana Kalyani3,
  • Daniël R. Prins1,
  • Susanne Weber2,
  • Christine Lammens4,
  • Leen Timbermont4,
  • Herman Goossens4,
  • Surbhi Malhotra-Kumar4,
  • Frangiscos Sifakis5,
  • Marc J. M. Bonten1, 6 and
  • Jan A. J. W. Kluytmans1, 7
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:643

https://doi.org/10.1186/s12879-017-2739-4

Received: 17 August 2017

Accepted: 14 September 2017

Published: 25 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 Aug 2017 Submitted Original manuscript
6 Sep 2017 Author responded Author comments - Fleur Paling
Resubmission - Version 2
6 Sep 2017 Submitted Manuscript version 2
12 Sep 2017 Author responded Author comments - Fleur Paling
Resubmission - Version 3
12 Sep 2017 Submitted Manuscript version 3
Publishing
14 Sep 2017 Editorially accepted
25 Sep 2017 Article published 10.1186/s12879-017-2739-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
(2)
Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
(3)
MedImmune, Gaithersburg, USA
(4)
Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium
(5)
AstraZeneca Pharmaceuticals LP, Gaithersburg, USA
(6)
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands
(7)
Amphia Hospital, Breda, The Netherlands

Advertisement